The purpose of this review was to show the available clinical and biological advances of umbilical cord blood allogeneic stem cell transplantation in adult patients. In adults, umbilical cord blood transplantation, due to less pronounced graft versus host disease compared to conventional approaches may, be feasible in spite of slower engraftment. The authors discussed certain attempts for improvement of umbilical cord stem cells engraftment.
Brunstein GC, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, BR B, et al. Umbilical cord blood transplan tation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematolo gic disease Blood 2007. 8(110):3064–70.
2.
Fernandez MN, Regidor C, R C. Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol. 2003;31:535–44.
3.
Fernandez MN, Regidor C, R C. Cord blood transplants: early recovery of neutrophils from co-tran splanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascerta ined by analysis of DNA polymorphisms. Bone Marrow Transplant. 2001;28:355–63.
4.
Cord blood transplants supported by co-infusion of mobilized he matopoietic stem cells from a third-party donor. Bone Marrow Transplant. 2009;43:365–73.
5.
Ballen KK, Spitzer TR, BY Y. Double unrela ted reduced-intensity umbilical cord blood transplan tation in adults. Biol Blood Marrow Transplant. 2007;13:82–9.
6.
Brunstein CB, Barker JN, DJ W. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant. 2009;43:935–40.
7.
Frassoni F, Gualandi F, Podestà M, Raiola AM, Ibatici A, Piaggio G, et al. Direct intrabone transplant of unre lated cord-blood cells in acute leukaemia: a phase I/II study. The Lancet Oncol. 2008;9(9):831–9.
8.
Castello S, Podesta M, Menditto VG, Ibatici A, Pitto A, O F, et al. Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding effici ency. Exp Haematol. 2004;8(32):782–7.
9.
Magrassi L, Castello S, Ciardelli L, Podesta M, A G, al CL. Freshly dissociated fetal neural stem /progenitor cells do not turn into blood. Mol Cell Neuro sci. 2003;2(22):179–87.
10.
Majhail N, Brunstein C, Wagner J. Double umbilical cord blood transplantation. Curr Opin Immunol. 2006;18:571–5.
11.
Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, E A, et al. Double unrelated reduced-intensity umbi lical cord blood transplantation in adults. Biol Blood Marrow Transplant. 2007;13:82–9.
12.
Transp BJNWSGCBTBBM. 2007;1(13):78–82.
13.
Wall DA. Chan KW Selection of cord blood unit(s) for transplantation. Bone Marrow Transplantation. 2008;42:1–7.
14.
E G, V R. Cord blood transplantation: state of the art. Hematologica. 2009;94:451–4.
15.
Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, M O, et al. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biol Blood Marrow Transplant. 2008;14:1–6.
16.
Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, KW C, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32:397–407.
17.
Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, EC H, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157 66.
18.
Tse W, Laughlin MJ. Umbilical Cord Blood Transplanta tion: A New Alternative Option, Hematology. ASH edu cation book. 2005;377–83.
19.
Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Gluckman HMM, et al. Graft-versus-host dise ase in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000;342:1846–54.
20.
F RVL. Searching for alternative hemato poietic stem cell donors for pediatric patients. Bone Marrow Transplantation. 2008;41:207–14.
21.
Khee WY, Samuel M, Tan D, Koh LP, Lim W, Linn YC. A Meta-Analysis of Unrelated Donor Umbilical Cord Blood Transplantation versus Unrelated Donor Bone Marrow Transplantation in Adult and Pediatric Patients. Biol Blood Marrow Trans. 2007;4(13):444–53.
22.
Bacigalupo A, Locatelli F, Lanino E, Marsh J, Socié G, S M, et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplan ts in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplan tation. 2005;36:947–50.
23.
Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, et al. Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;3(105):1343–7.
24.
Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, A B, et al. Transplants of umbilical cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;22(351):2276 85.
25.
Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, RE C, et al. Outcomes after tran splantation of cord blood or bone marrow from unrela ted donors in adults with leukemia. N Engl J Med. 2004;22(351):2265–75.
26.
Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, JE W, et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med. 2001;24(344):1815–22.
27.
Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical cord blood transplantation in children with malignant and non malignant disease. Lancet. 1995;8969(346):214–9.
28.
Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced - intensity conditioning. Blood. 2003;5(102):1915–9.
29.
Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor um bilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;5(100):1611–8.
30.
Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, AR M, et al. Outcomes among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med. 1998;22(339):1565–77.
31.
Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, R P, et al. Outcome of cord blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group N Engl J Med. 1997;6(337):373–81.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
